Literature DB >> 367510

Treatment and survival on advanced breast cancer.

T Priestman, M Baum, V Jones, J Forbes.   

Abstract

The final results of a clinical trial comparing endocrine with cytotoxic drug treatment for advanced breast cancer were analysed. Although cytotoxic treatment gave a significantly higher response rate with a remission duration comparable to that obtained with endocrine treatment, the sequence in which the two treatments were given did not appear to influence survival--except possibly in women with rapidly progressing disease, when cytotoxic treatment is preferred.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 367510      PMCID: PMC1608971          DOI: 10.1136/bmj.2.6153.1673

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

Review 1.  Therapeutic significance of sex-steroid hormone receptors in the treatment of breast cancer.

Authors:  G Leclercq; J C Heuson
Journal:  Eur J Cancer       Date:  1977-11       Impact factor: 9.162

2.  Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer.

Authors:  T Priestman; M Baum; V Jones; J Forbes
Journal:  Br Med J       Date:  1977-05-14
  2 in total
  6 in total

1.  Effect of chemotherapy on survival in metastatic breast cancer.

Authors:  A H Paterson; O Szafran; F Cornish; A W Lees; J Hanson
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

Review 2.  Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.

Authors:  N Wilcken; J Hornbuckle; D Ghersi
Journal:  Cochrane Database Syst Rev       Date:  2003

3.  Does chemotherapy improve survival in advanced breast cancer? A statistical overview.

Authors:  R P A'Hern; S R Ebbs; M B Baum
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

4.  Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials.

Authors:  M Baum
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

5.  Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.

Authors:  H Gabra; D A Cameron; L E Lee; J Mackay; R C Leonard
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

6.  Quality of life after cytotoxic chemotherapy: discussion paper.

Authors:  T J Priestman
Journal:  J R Soc Med       Date:  1984-06       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.